Merriman Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $210K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $224K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $215K | Hold |
|
|||||
|
2023
Q2 | $237K | Buy |
|
|||||
|
2023
Q1 | $254K | Sell |
|
|||||
|
2022
Q4 | $268K | Buy |
|
|||||
|
2022
Q3 | $249K | Sell |
|
|||||
|
2022
Q2 | $271K | Sell |
|
|||||
|
2022
Q1 | $270K | Buy |
|
|||||
|
2021
Q4 | $209K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $218K | Sell |
|
|||||
|
2021
Q1 | $206K | Sell |
|
|||||
|
2020
Q4 | $281K | Buy |
|
|||||
|
2020
Q3 | $212K | Sell |
|
|||||
|
2020
Q2 | $216K | Sell |
|
|||||
|
2020
Q1 | $255K | Sell |
|
|||||
|
2019
Q4 | $320K | Buy |
|
|||||
|
2019
Q3 | $214K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $240K | Buy |
|
|||||
|
2018
Q2 | $213K | Sell |
|
|||||
|
2018
Q1 | $277K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $219K | Buy |
|